Though Systolic BP Seems More Important, Diastolic BP Should Not Be Disregarded

Systolic hypertension is more often associated to cardiovascular events. However, diastolic blood pressure should not be disregarded, since it can also predict even worse outcomes.

Oportunidades perdidas en pacientes con enfermedad vascular periférica

Although systolic blood pressure is very frequently associated to adverse cardiovascular events, by no means should diastolic blood pressure be considered unimportant.

Such is the message of this study recently published in NEJM including data from more than 1.3 million outpatients, which shows that both systolic and diastolic hypertension are independently associated to cardiovascular events in the long run (acute myocardial infarction, ischemic or hemorrhagic stroke) regardless the type of blood pressure we might be focusing on.

Diastolic pressure should not be ignored, and we should focus on both BP goals (systolic and diastolic) for both hypertension diagnosis and treatment, to maximize the chances of therapy and effectively reduce population risk. According to the study authors, the AHA/ACC goals are reasonable and well founded, which is why they suggest aggressive treatment, especially when it comes to higher risk patients.


Read also: Dietary Supplements and Diets Show No Impact on Cardiovascular Risk.


They believe the J shaped curve should be of no concern.

The analysis included 36.8 million registries on blood pressure automatically measured. Using 140/90 as threshold, 18.9% presented hypertension, but when using 130/80 the incidence increased to 43.5%!!!

Regardless the BP definition we might choose, both systolic and diastolic pressure are independently associated to adverse events at 8 year follow up.

The correlation was stronger for systolic blood pressure.


Read also: Supervised Exercise and Revascularization for Intermittent Claudication.


The authors also explored the J shape curve previously observed between diastolic BP and events. This non-adjusted analysis showed increased risk both for peak and valley thresholds, but when adjusting by age, race and other comorbidities, the risk at the bottom of the curve disappeared.

According to this study, the J shape in this population (mostly healthy, mean age 53) is not a problem, so we should be more aggressive in trying to reach the proposed goals with no regard of the J curve, since after adjusting for variables, the risk in the lowest quartile disappears.

Título original: Effect of systolic and diastolic blood pressure on cardiovascular outcomes.

Referencia: Flint AC et al. N Engl J Med. 2019;381:243-251.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

How real are the adverse effects of statins? Evidence from randomized clinical trials

The safety of statins continues to be a subject of debate, partly due to the extensive list of adverse effects included in prescribing information,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...